194 related articles for article (PubMed ID: 27933411)
21. Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology.
Bjelic-Radisic V; Singer C; Tamussino K; Kölbl H; Petru E; Volgger B; Polterauer S; Oppelt P; Sevelda P; Bogner G; Marth C;
Wien Klin Wochenschr; 2019 May; 131(9-10):233-236. PubMed ID: 30887224
[TBL] [Abstract][Full Text] [Related]
22. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
[TBL] [Abstract][Full Text] [Related]
23. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
24. The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer.
Narod SA
Breast Cancer Res Treat; 2011 Jul; 128(2):581-3. PubMed ID: 21455666
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy.
Chagpar AB
Surg Oncol Clin N Am; 2014 Jul; 23(3):423-30. PubMed ID: 24882342
[TBL] [Abstract][Full Text] [Related]
26. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
[TBL] [Abstract][Full Text] [Related]
27. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
McLaughlin CC; Lillquist PP; Edge SB
Cancer; 2009 Dec; 115(23):5404-12. PubMed ID: 19787635
[TBL] [Abstract][Full Text] [Related]
28. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
Huang J; Chagpar A
J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
[TBL] [Abstract][Full Text] [Related]
29. What surgical oncology providers and women with sporadic breast cancer should not forget in the decision-making about contralateral prophylactic mastectomy!
Franceschini G; Di Leone A; Masetti R
Transl Behav Med; 2020 May; 10(2):364-365. PubMed ID: 30698813
[No Abstract] [Full Text] [Related]
30. Increase in contralateral prophylactic mastectomy conversation online unrelated to decision-making.
Marmor RA; Dai W; Jiang X; Wang S; Blair SL; Huh J
J Surg Res; 2017 Oct; 218():253-260. PubMed ID: 28985858
[TBL] [Abstract][Full Text] [Related]
31. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
[TBL] [Abstract][Full Text] [Related]
32. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
33. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
Tercyak KP; Peshkin BN; Brogan BM; DeMarco T; Pennanen MF; Willey SC; Magnant CM; Rogers S; Isaacs C; Schwartz MD
J Clin Oncol; 2007 Jan; 25(3):285-91. PubMed ID: 17159191
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic surgery to reduce breast cancer risk: a brief literature review.
Anderson BO
Breast J; 2001; 7(5):321-30. PubMed ID: 11906442
[TBL] [Abstract][Full Text] [Related]
35. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
[TBL] [Abstract][Full Text] [Related]
36. Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer.
Chen H; Zhang P; Zhang M; Wang M; Bai F; Wu K
J Surg Res; 2019 Jul; 239():224-232. PubMed ID: 30856515
[TBL] [Abstract][Full Text] [Related]
37. "I don't want to take chances.": A qualitative exploration of surgical decision making in young breast cancer survivors.
Rosenberg SM; Greaney ML; Patenaude AF; Sepucha KR; Meyer ME; Partridge AH
Psychooncology; 2018 Jun; 27(6):1524-1529. PubMed ID: 29476578
[TBL] [Abstract][Full Text] [Related]
38. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
39. Contralateral prophylactic mastectomy: quantifying benefits and weighing the harms.
Helzlsouer KJ
J Clin Oncol; 2005 Jul; 23(19):4251-3. PubMed ID: 15795414
[No Abstract] [Full Text] [Related]
40. Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic Mastectomy.
Nass SJ; Nekhlyudov L
Ann Surg Oncol; 2017 Mar; 24(3):611-613. PubMed ID: 28058555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
